74 research outputs found

    Muon-spin-rotation measurements of the penetration depth in Li_2Pd_3B

    Full text link
    Measurements of the magnetic field penetration depth λ\lambda in the ternary boride superconductor Li2_2Pd3_3B (Tc≃7.3T_c\simeq7.3 K) have been carried out by means of muon-spin rotation (ÎŒ\muSR). The absolute values of λ\lambda, the Ginzburg-Landau parameter Îș\kappa, and the first Hc1H_{c1} and the second Hc2H_{c2} critical fields at T=0 obtained from ÎŒ\muSR were found to be λ(0)=252(2)\lambda(0)=252(2) nm, Îș(0)=27(1)\kappa(0)=27(1), ÎŒ0Hc1(0)=9.5(1)\mu_0H_{c1}(0)=9.5(1) mT, and ÎŒ0Hc2(0)=3.66(8)\mu_0H_{c2}(0)=3.66(8) T, respectively. The zero-temperature value of the superconducting gap Δ0=\Delta_0=1.31(3) meV was found, corresponding to the ratio 2Δ0/kBTc=4.0(1)2\Delta_0/k_BT_c=4.0(1). At low temperatures λ(T)\lambda(T) saturates and becomes constant below T≃0.2TcT\simeq 0.2T_c, in agreement with what is expected for s-wave BCS superconductors. Our results suggest that Li2_2Pd3_3B is a s-wave BCS superconductor with the only one isotropic energy gap.Comment: 6 pages, 7 figure

    Study of the magnetic penetration depth in RbOs_2O_6

    Full text link
    Measurements of the magnetic field penetration depth \lambda in the pyrochlore superconductor RbOs_2O_6 (T_c\simeq6.3 K) were carried out by means of the muon-spin-rotation (\muSR) technique. At low temperatures \lambda^{-2}(T) saturates and becomes constant below T\simeq 0.2T_c, in agreement with what is expected for weak-coupled s-wave BCS superconductors. The value of \lambda at T=0 was found to be in the range of 250 nm to 300 nm. \muSR and equilibrium magnetization measurements both reveal that at low temperatures λ\lambda is almost (at the level of 10%) independent of the applied magnetic field. This result suggests that the superconducting energy gap in RbOs_2O_6 is isotropic.Comment: 8 pages, 9 figure

    Pressure effects on the transition temperature and the magnetic field penetration depth in the pyrochlore superconductor RbOs_2O_6

    Full text link
    We report magnetization measurements under high hydrostatic pressure in the newly discovered pyrochlore superconductor RbOs_2O_6 (T_c\simeq6.3K at p=0). A pronounced and {\it positive} pressure effect (PE) on T_c with dT_c/dp =0.090(1)K/kbar was observed, whereas no PE on the magnetic penetration depth \lambda was detected. The relative pressure shift of T_c [ dlnT_c/dp \simeq 1.5%/kbar] is comparable with the highest values obtained for highly underdoped high-temperature cuprate superconductors. Our results suggest that RbOs_2O_6 is an adiabatic BCS-type superconductor.Comment: 11 pages, 4 figure

    Jacobsen syndrome

    Get PDF
    Jacobsen syndrome is a MCA/MR contiguous gene syndrome caused by partial deletion of the long arm of chromosome 11. To date, over 200 cases have been reported. The prevalence has been estimated at 1/100,000 births, with a female/male ratio 2:1. The most common clinical features include pre- and postnatal physical growth retardation, psychomotor retardation, and characteristic facial dysmorphism (skull deformities, hypertelorism, ptosis, coloboma, downslanting palpebral fissures, epicanthal folds, broad nasal bridge, short nose, v-shaped mouth, small ears, low set posteriorly rotated ears). Abnormal platelet function, thrombocytopenia or pancytopenia are usually present at birth. Patients commonly have malformations of the heart, kidney, gastrointestinal tract, genitalia, central nervous system and skeleton. Ocular, hearing, immunological and hormonal problems may be also present. The deletion size ranges from ~7 to 20 Mb, with the proximal breakpoint within or telomeric to subband 11q23.3 and the deletion extending usually to the telomere. The deletion is de novo in 85% of reported cases, and in 15% of cases it results from an unbalanced segregation of a familial balanced translocation or from other chromosome rearrangements. In a minority of cases the breakpoint is at the FRA11B fragile site. Diagnosis is based on clinical findings (intellectual deficit, facial dysmorphic features and thrombocytopenia) and confirmed by cytogenetics analysis. Differential diagnoses include Turner and Noonan syndromes, and acquired thrombocytopenia due to sepsis. Prenatal diagnosis of 11q deletion is possible by amniocentesis or chorionic villus sampling and cytogenetic analysis. Management is multi-disciplinary and requires evaluation by general pediatrician, pediatric cardiologist, neurologist, ophthalmologist. Auditory tests, blood tests, endocrine and immunological assessment and follow-up should be offered to all patients. Cardiac malformations can be very severe and require heart surgery in the neonatal period. Newborns with Jacobsen syndrome may have difficulties in feeding and tube feeding may be necessary. Special attention should be devoted due to hematological problems. About 20% of children die during the first two years of life, most commonly related to complications from congenital heart disease, and less commonly from bleeding. For patients who survive the neonatal period and infancy, the life expectancy remains unknown

    Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study

    Get PDF
    Background: The National Research Council (CNR) prostate cancer monitoring project in Italy (Pros-IT CNR) is an observational, prospective, ongoing, multicentre study aiming to monitor a sample of Italian males diagnosed as new cases of prostate cancer. The present study aims to present data on the quality of life at time prostate cancer is diagnosed. Methods: One thousand seven hundred five patients were enrolled. Quality of life is evaluated at the time cancer was diagnosed and at subsequent assessments via the Italian version of the University of California Los Angeles-Prostate Cancer Index (UCLA-PCI) and the Short Form Health Survey (SF-12). Results: At diagnosis, lower scores on the physical component of the SF-12 were associated to older ages, obesity and the presence of 3+ moderate/severe comorbidities. Lower scores on the mental component were associated to younger ages, the presence of 3+ moderate/severe comorbidities and a T-score higher than one. Urinary and bowel functions according to UCLA-PCI were generally good. Almost 5% of the sample reported using at least one safety pad daily to control urinary loss; less than 3% reported moderate/severe problems attributable to bowel functions, and sexual function was a moderate/severe problem for 26.7%. Diabetes, 3+ moderate/severe comorbidities, T2 or T3-T4 categories and a Gleason score of eight or more were significantly associated with lower sexual function scores at diagnosis. Conclusions: Data collected by the Pros-IT CNR study have clarified the baseline status of newly diagnosed prostate cancer patients. A comprehensive assessment of quality of life will allow to objectively evaluate outcomes of different profile of care

    Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes

    Get PDF
    Background: Albuminuria has been classically considered a marker of kidney damage progression in diabetic patients and it is routinely assessed to monitor kidney function. However, the role of a mild GFR reduction on the development of stage 653 CKD has been less explored in type 1 diabetes mellitus (T1DM) patients. Aim of the present study was to evaluate the prognostic role of kidney disease measures, namely albuminuria and reduced GFR, on the development of stage 653 CKD in a large cohort of patients affected by T1DM. Methods: A total of 4284 patients affected by T1DM followed-up at 76 diabetes centers participating to the Italian Association of Clinical Diabetologists (Associazione Medici Diabetologi, AMD) initiative constitutes the study population. Urinary albumin excretion (ACR) and estimated GFR (eGFR) were retrieved and analyzed. The incidence of stage 653 CKD (eGFR < 60 mL/min/1.73 m2) or eGFR reduction > 30% from baseline was evaluated. Results: The mean estimated GFR was 98 \ub1 17 mL/min/1.73m2 and the proportion of patients with albuminuria was 15.3% (n = 654) at baseline. About 8% (n = 337) of patients developed one of the two renal endpoints during the 4-year follow-up period. Age, albuminuria (micro or macro) and baseline eGFR < 90 ml/min/m2 were independent risk factors for stage 653 CKD and renal function worsening. When compared to patients with eGFR > 90 ml/min/1.73m2 and normoalbuminuria, those with albuminuria at baseline had a 1.69 greater risk of reaching stage 3 CKD, while patients with mild eGFR reduction (i.e. eGFR between 90 and 60 mL/min/1.73 m2) show a 3.81 greater risk that rose to 8.24 for those patients with albuminuria and mild eGFR reduction at baseline. Conclusions: Albuminuria and eGFR reduction represent independent risk factors for incident stage 653 CKD in T1DM patients. The simultaneous occurrence of reduced eGFR and albuminuria have a synergistic effect on renal function worsening
    • 

    corecore